BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24888524)

  • 1. A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophrenia.
    Boley AM; Perez SM; Lodge DJ
    Schizophr Res; 2014 Aug; 157(1-3):238-43. PubMed ID: 24888524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia.
    Chen L; Perez SM; Lodge DJ
    Dev Neurobiol; 2014 Sep; 74(9):907-17. PubMed ID: 24554310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia.
    Lodge DJ; Grace AA
    Int J Neuropsychopharmacol; 2012 Feb; 15(1):69-76. PubMed ID: 21329556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.
    Gomes FV; Guimarães FS; Grace AA
    Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Region specific knockdown of Parvalbumin or Somatostatin produces neuronal and behavioral deficits consistent with those observed in schizophrenia.
    Perez SM; Boley A; Lodge DJ
    Transl Psychiatry; 2019 Oct; 9(1):264. PubMed ID: 31636253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia.
    Gill KM; Lodge DJ; Cook JM; Aras S; Grace AA
    Neuropsychopharmacology; 2011 Aug; 36(9):1903-11. PubMed ID: 21562483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A loss of hippocampal perineuronal nets produces deficits in dopamine system function: relevance to the positive symptoms of schizophrenia.
    Shah A; Lodge DJ
    Transl Psychiatry; 2013 Jan; 3(1):e215. PubMed ID: 23321812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.
    Gill KM; Cook JM; Poe MM; Grace AA
    Schizophr Bull; 2014 Mar; 40(2):341-50. PubMed ID: 24464874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of Lhx6 during embryonic development results in neurophysiological alterations and behavioral deficits analogous to schizophrenia in adult rats.
    Elam HB; Perez SM; Donegan JJ; Eassa NE; Lodge DJ
    Schizophr Res; 2024 May; 267():113-121. PubMed ID: 38531158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal interneuron transplants reverse aberrant dopamine system function and behavior in a rodent model of schizophrenia.
    Perez SM; Lodge DJ
    Mol Psychiatry; 2013 Nov; 18(11):1193-8. PubMed ID: 23979606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia-Like Phenotype Inherited by the F2 Generation of a Gestational Disruption Model of Schizophrenia.
    Perez SM; Aguilar DD; Neary JL; Carless MA; Giuffrida A; Lodge DJ
    Neuropsychopharmacology; 2016 Jan; 41(2):477-86. PubMed ID: 26068729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia.
    Lodge DJ; Grace AA
    J Neurosci; 2007 Oct; 27(42):11424-30. PubMed ID: 17942737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing endocannabinoid levels in the ventral pallidum restore aberrant dopamine neuron activity in the subchronic PCP rodent model of schizophrenia.
    Aguilar DD; Chen L; Lodge DJ
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.
    Gill KM; Miller SA; Grace AA
    Schizophr Res; 2018 May; 195():343-352. PubMed ID: 28927551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orchestration of Dopamine Neuron Population Activity in the Ventral Tegmental Area by Caffeine: Comparison With Amphetamine.
    Valenti O; Zambon A; Boehm S
    Int J Neuropsychopharmacol; 2021 Oct; 24(10):832-841. PubMed ID: 34278424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medial septum differentially regulates dopamine neuron activity in the rat ventral tegmental area and substantia nigra via distinct pathways.
    Bortz DM; Grace AA
    Neuropsychopharmacology; 2018 Sep; 43(10):2093-2100. PubMed ID: 29654260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convergent Inputs from the Hippocampus and Thalamus to the Nucleus Accumbens Regulate Dopamine Neuron Activity.
    Perez SM; Lodge DJ
    J Neurosci; 2018 Dec; 38(50):10607-10618. PubMed ID: 30355626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia.
    Lodge DJ; Grace AA
    Neurotox Res; 2008 Oct; 14(2-3):97-104. PubMed ID: 19073417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal from Acute Amphetamine Induces an Amygdala-Driven Attenuation of Dopamine Neuron Activity: Reversal by Ketamine.
    Belujon P; Jakobowski NL; Dollish HK; Grace AA
    Neuropsychopharmacology; 2016 Jan; 41(2):619-27. PubMed ID: 26129677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parvalbumin and GAD65 interneuron inhibition in the ventral hippocampus induces distinct behavioral deficits relevant to schizophrenia.
    Nguyen R; Morrissey MD; Mahadevan V; Cajanding JD; Woodin MA; Yeomans JS; Takehara-Nishiuchi K; Kim JC
    J Neurosci; 2014 Nov; 34(45):14948-60. PubMed ID: 25378161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.